The term “liberated information” may sound like it was taken from a science fiction novel, but to General Electric’s (NYSE:GE) Earl Jones, it’s a means to improve access and quality to healthcare while at the same time making it cheaper. Jones is the vice president and general manager of the eHealth division of GE Healthcare, overseeing the development of information technology platforms that customers ranging from small doctors’ offices to state governments are implementing into their everyday operations.
Each week, the DeviceTalks podcast will bring the energy and insights of our events to you via iTunes, Spotify and other podcasts channels. Hosted by our DeviceTalks Editorial Director Tom Salemi, the DeviceTalks podcast will tell the stories of the entrepreneurs, executives and other leaders who have committed their careers to making Medtech better.
DeviceTalks Editorial Director Tom Salemi brings over two decades of Medtech writing to each episode of DeviceTalks. Prior to joining WTWH Media, Tom organized conferences, wrote feature articles, broke news and hosted an influential podcast. Tom grew up outside of Boston, so he’s thrilled to be organizing this region’s most influential Medtech meeting. Tom lives north of Boston with his wife, two sons, and Daisy the Dog.
The man Stanford University once dubbed “The Mickey Mantle of medical device inventors” still has his swing, or at least his sway in the industry, judging by the reaction Dr. Thomas Fogarty received in Boston recently at a round-table discussion of medical device innovation.
For William Hawkins, Medtronic Inc. (NYSE:MDT) runs in the family.
Inside his corner office at the Fridley, Minn.-based medical device goliath, Hawkins, chairman and CEO of one of the world’s largest medical device companies, keeps a picture of two customers he says not only shaped how he sees his company but how he sees the world.
InfraReDx Inc. is on a roll this fall. The Burlington, Mass.-based medical device maker won 510(k) clearance from the Food & Drug Administration in early September for its LipiScan IVUS coronary imaging system and pulled in $21 million in an equity offering a month later, which it plans to use to fund the U.S. rollout of the device.
The LipiScan IVUS uses both so-called “near-infrared” spectroscopy and intravascular ultrasound technology to give cardiologists a grayscale IVUS image of a coronary artery, along with a map of lipid core coronary plaques within a blood vessel.